Table 6 Five-year survival and crude and adjusted hazard ratios by sociodemograhic and clinical factors (n = 3,297).
Characteristic | 5 yr Survival1(%) | Crude Hazard Ratio (95% CI)2 | Adjusted3Hazard Ratio (95% CI) | ||||
|---|---|---|---|---|---|---|---|
Age at diagnosis | Â | Â | Â | Â | Â | ||
   <60 | 95.06 | 1.00 | (referent) | 1.00 | (referent) | ||
   60-64 | 93.38 | 1.38 | (0.86 - 2.20) | 1.28 | (0.80 - 2.04) | ||
   65-69 | 87.92 | 2.59 | (1.73 - 3.89) | 2.10 | (1.39 - 3.18) | ||
   70-74 | 85.60 | 3.33 | (2.24 - 4.95) | 2.28 | (1.51 - 3.46) | ||
   75-79 | 74.67 | 6.18 | (4.18 - 9.14) | 3.67 | (2.41 - 5.60) | ||
   >= 80 | 50.82 | 13.00 | (8.78 - 19.25) | 5.29 | (3.43 - 8.16) | ||
Race/ethnicity | Â | Â | Â | Â | Â | ||
   Non-Hispanic White | 85.42 | 1.00 | (referent) | 1.00 | (referent) | ||
   Non-Hispanic Black | 78.78 | 1.47 | (1.18 - 1.83) | 1.17 | (0.92 - 1.48) | ||
   Non-Hispanic Other | 94.51 | 0.31 | (0.10 - 0.95) | 0.35 | (0.11 - 1.10) | ||
   Hispanic | 92.65 | 0.51 | (0.27 - 0.96) | 0.53 | (0.28 - 1.00) | ||
   Unknown | 78.25 | 1.40 | (0.52 - 3.74) | 1.29 | (0.46 - 3.61) | ||
Marital status | Â | Â | Â | Â | Â | ||
   Married | 86.36 | 1.00 | (referent) | 1.00 | (referent) | ||
   Not Married | 78.58 | 1.69 | (1.40 - 2.05) | 1.21 | (1.00 - 1.48) | ||
   Unknown | 86.39 | 0.90 | (0.59 - 1.35) | 0.67 | (0.43 - 1.03) | ||
Registry | Â | Â | Â | Â | Â | ||
   California | 86.03 | 1.00 | (referent) | 1.00 | (referent) | ||
   Colorado | 89.97 | 0.79 | (0.56 - 1.10) | 0.94 | (0.66 - 1.33) | ||
   Illinois | 82.36 | 1.35 | (1.00 - 1.82) | 1.01 | (0.74 - 1.38) | ||
   Louisiana | 78.80 | 1.69 | (1.28 - 2.25) | 1.37 | (1.02 - 1.84) | ||
   New York | 86.90 | 1.01 | (0.73 - 1.40) | 1.10 | (0.78 - 1.54) | ||
   Rhode Island | 88.38 | 0.91 | (0.65 - 1.27) | 0.82 | (0.58 - 1.16) | ||
   South Carolina | 79.79 | 1.72 | (1.21 - 2.44) | 1.54 | (1.06 - 2.24) | ||
PSA value | Â | Â | Â | Â | Â | ||
   0-4 | 90.49 | 1.00 | (referent) | 1.00 | (referent) | ||
   >4-10 | 89.28 | 1.00 | (0.69 - 1.44) | 1.07 | (0.73 - 1.55) | ||
   >10-20 | 84.65 | 1.50 | (1.01 - 2.21) | 1.20 | (0.81 - 1.79) | ||
   20+ | 75.77 | 2.43 | (1.64 - 3.60) | 1.38 | (0.92 - 2.09) | ||
   Unknown | 73.16 | 2.65 | (1.80 - 3.90) | 1.82 | (1.22 - 2.70) | ||
Gleason score | Â | Â | Â | Â | Â | ||
   2-4 | 83.90 | 1.00 | (referent) | 1.00 | (referent) | ||
   5-7 | 86.73 | 1.10 | (0.81 - 1.50) | 1.35 | (0.98 - 1.85) | ||
   8-10 | 73.69 | 2.21 | (1.54 - 3.19) | 1.96 | (1.34 - 2.86) | ||
   Unknown | 74.52 | 2.29 | (1.55 - 3.38) | 1.69 | (1.13 - 2.51) | ||
Treatment | Â | Â | Â | Â | Â | ||
   Radical prostatectomy | 93.68 | 1.00 | (referent) | 1.00 | (referent) | ||
   Radiation therapy | 85.99 | 2.55 | (1.97 - 3.31) | 1.66 | (1.24 - 2.21) | ||
   Hormonal therapy | 65.24 | 6.75 | (5.13 - 8.88) | 2.83 | (2.06 - 3.90) | ||
   Watchful waiting | 75.47 | 4.73 | (3.65 - 6.14) | 2.30 | (1.70 - 3.12) | ||
Comorbidity score4 | Â | Â | Â | Â | Â | ||
   ≤1 year post diagnosis |  |  |  |  |  | ||
   0 | 86.69# | 1.00 | (referent) | 1.00 | (referent) | ||
   1 | 79.68# | 2.84 | (1.39 - 5.81) | 2.16 | (1.05 - 4.41) | ||
   2+ | 62.62# | 9.90 | (4.78 - 20.88) | 6.39 | (3.04 - 13.42) | ||
   >1 to 3 years post diagnosis |  |  |  |  |  | ||
   0 |  | 1.00 | (referent) | 1.00 | (referent) | ||
   1 |  | 1.56 | (1.08 - 2.26) | 1.20 | (0.83 - 1.74) | ||
   2+ |  | 3.99 | (2.52 - 6.31) | 2.67 | (1.68 - 4.25) | ||
   >3 years post diagnosis |  |  |  |  |  | ||
   0 |  | 1.00 | (referent) | 1.00 | (referent) | ||
   1 |  | 1.48 | (1.09 - 2.00) | 1.22 | (0.90 - 1.66) | ||
   2+ |  | 2.16 | (1.30 - 3.58) | 1.47 | (0.88 - 2.45) | ||